Imipenem
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB01598 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 100 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | diffuse scleroderma | KG + DL |
| 2 | paratyphoid fever | KG + DL |
| 3 | salmonellosis | KG + DL |
| 4 | sinusitis | KG + DL |
| 5 | chronic rhinosinusitis | KG + DL |
| 6 | typhoid fever | KG + DL |
| 7 | chronic ethmoidal sinusitis | KG + DL |
| 8 | paranasal sinus neoplasm (disease) | KG + DL |
| 9 | staphylococcus aureus infection | KG + DL |
| 10 | eosinophilia-myalgia syndrome | KG + DL |
| 11 | infectious otitis media | KG + DL |
| 12 | epiglottitis | KG + DL |
| 13 | conjunctivitis | KG + DL |
| 14 | scleroderma, familial progressive | KG + DL |
| 15 | suppurative otitis media | KG + DL |
| 16 | chronic otitis media | KG + DL |
| 17 | staphylococcal infection | KG + DL |
| 18 | middle ear disease | KG + DL |
| 19 | bronchitis | KG + DL |
| 20 | otosalpingitis | KG + DL |
| 21 | non-suppurative otitis media | KG + DL |
| 22 | staphylococcal toxemia | KG + DL |
| 23 | staphylococcal scarlet fever | KG + DL |
| 24 | allergic otitis media | KG + DL |
| 25 | staphylococcal pneumonia | KG + DL |
| 26 | limited scleroderma | KG + DL |
| 27 | salmonella infections, animal | KG + DL |
| 28 | middle ear cholesterol granuloma | KG + DL |
| 29 | meningococcal infection | KG + DL |
| 30 | pneumonia | KG + DL |
| 31 | abdominal tuberculosis | KG + DL |
| 32 | urinary tract infection (disease) | KG + DL |
| 33 | necrotizing ulcerative gingivitis | KG + DL |
| 34 | Lyme disease | KG + DL |
| 35 | invasive non-typhoidal salmonellosis | KG + DL |
| 36 | hordeolum externum | KG + DL |
| 37 | gonococcal urethritis | KG + DL |
| 38 | Ureaplasma urethritis | KG + DL |
| 39 | membranous glomerulonephritis | KG + DL |
| 40 | lymphogranuloma venereum | KG + DL |
| 41 | hyperamylasemia | KG + DL |
| 42 | polyclonal hyperviscosity syndrome | KG + DL |
| 43 | myalgia-eosinophilia syndrome associated with tryptophan | KG + DL |
| 44 | laryngitis | KG + DL |
| 45 | chronic gingivitis | KG + DL |
| 46 | gingivitis | KG + DL |
| 47 | endocardial fibroelastosis | KG + DL |
| 48 | congenital analbuminemia | KG + DL |
| 49 | Moyamoya disease | KG + DL |
| 50 | acute gonococcal cervicitis | KG + DL |
(Showing top 50 of 100 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.